Spironolactone, a blood pressure medication, may help reduce risk of new heart failure
November 17, 2024
November 17, 2024
DALLAS, Texas, Nov. 17 [Category: Health Care] -- The American Heart Association issued the following news release:
Research Highlights:
The CLEAR SYNERGY trial found that spironolactone may reduce the risk of new or worsening heart failure; however, it did not significantly impact the rate of death, new heart attack or stroke.
More research is needed to further explore the potential for spironolactone, a blood pressure medication, to prevent heart failure . . .
Research Highlights:
The CLEAR SYNERGY trial found that spironolactone may reduce the risk of new or worsening heart failure; however, it did not significantly impact the rate of death, new heart attack or stroke.
More research is needed to further explore the potential for spironolactone, a blood pressure medication, to prevent heart failure . . .